Genovis AB (publ.) Capital Reinvestment Ratio

Latest as of December 2025: 1.00x

Genovis AB (publ.) capital reinvestment ratio. Genovis AB (publ.) (GENO) has a Capital Reinvestment Ratio of 1.00x as of December 2025, meaning it reinvests 1% of its operating cash flow (Skr15.90 Million) in capital expenditures (Skr15.90 Million). Check Genovis AB (publ.) (GENO) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

1.00x
Capex / Operating Cash Flow

Operating Cash Flow

Skr15.90 Million
SEK

Capital Expenditures

Skr15.90 Million
SEK

Data as of

Dec 2025
Most recent filing

Capital Reinvestment Ratio of Genovis AB (publ.) (2019–2025)

Capital reinvestment ratio of Genovis AB (publ.) from 2019 to 2025. This chart tracks Genovis AB (publ.)'s Capital Reinvestment Ratio across 6 annual periods. Also explore net asset momentum of Genovis AB (publ.) to track the company's year-over-year net asset growth rate.

Genovis AB (publ.) Capital Reinvestment Ratio by Year (2019–2025)

Genovis AB (publ.) capital reinvestment ratio by year from 2019 to 2025. For the full cash flow conversion analysis, see Genovis AB (publ.) cash flow conversion.

Year Reinvestment Ratio Operating CF (SEK) Capital Expenditures YoY Change
2025 1.00x Skr32.02 Million Skr32.02 Million ▲ +3314.5%
2024 0.03x Skr37.12 Million Skr1.09 Million ▼ -84.5%
2023 0.19x Skr67.75 Million Skr12.81 Million ▲ +93.3%
2021 0.10x Skr45.92 Million Skr4.49 Million ▼ -98.2%
2020 5.44x Skr3.76 Million Skr20.43 Million ▲ +1285.5%
2019 0.39x Skr13.13 Million Skr5.15 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow